Serbia Oncology NGS Market (2025-2031) | Outlook, Companies, Trends, Segmentation, Value, Growth, Analysis, Industry, Forecast, Share, Size & Revenue, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Serbia Country Macro Economic Indicators

3.2 Serbia Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Serbia Oncology NGS Market - Industry Life Cycle

3.4 Serbia Oncology NGS Market - Porter's Five Forces

3.5 Serbia Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Serbia Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Serbia Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Serbia Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Serbia Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Serbia

4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology research

4.2.3 Government initiatives and funding for cancer research and treatment

4.3 Market Restraints

4.3.1 High cost associated with NGS technology and testing

4.3.2 Limited awareness and expertise in NGS technology among healthcare professionals in Serbia

6.1 Serbia Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Serbia Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Serbia Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Serbia Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Serbia Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Serbia Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Serbia Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Serbia Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Serbia Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Serbia Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Serbia Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Serbia Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Serbia Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Serbia Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Serbia Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Serbia Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Serbia Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Serbia Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Serbia Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Serbia Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Serbia Oncology NGS Market Export to Major Countries

7.2 Serbia Oncology NGS Market Imports from Major Countries

8.1 Number of oncology NGS tests conducted annually in Serbia

8.2 Adoption rate of NGS technology in oncology research and clinical practice

8.3 Number of research studies and publications utilizing NGS technology in oncology in Serbia

9.1 Serbia Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Serbia Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Serbia Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Serbia Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Serbia Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Serbia Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Serbia Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters